학술논문
Qualitative Analysis of the Treatment Experience and Well-Being of Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Enrolled in 2 Trials of Lisocabtagene Maraleucel (liso-cel) during the Initial Stages of Therapy
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:22-23
Subject
Language
ISSN
0006-4971